Article

Address pupil ovalization after IOL implantation promptly

Lisbon, Portugal – Pupil ovalization after implantation of IOLs is a rare occurrence. However, when it develops, it must be addressed immediately and effectively, according to Antonio Marinho, MD, PhD, of the University of Porto, Portugal.

Lisbon, Portugal – Pupil ovalization after implantation of IOLs is a rare occurrence. However, when it develops, it must be addressed immediately and effectively, according to Antonio Marinho, MD, PhD, of the University of Porto, Portugal.

Dr. Marinho reported a challenging case of pupil distortion in a 25-year-old female patient. The woman had undergone IOL implantation in 1994 because of a case of high myopia (–14 D). Her best-corrected visual acuity was 20/30 before surgery. The uncorrected visual acuity was 20/25 with the IOL implanted. In 2003, when the patient presented for a routine examination, the pupil was distorted, and there was important iris atrophy; however, the patient had no glare and did not have any visual complaints.  The IOL had to be removed despite lack of symptoms.

Dr. Marinho explained Saturday at the European Society of Cataract and Refractive Surgeons that there are a few management options in such cases that include observation, rotation of the IOL, and explanation of the IOL. The first two were no options in this case. Regarding explantation, in this case he opted for replacing the IOL with another phakic IOL and avoided the areas of iris atrophy. Partial reversibility of the pupil distortion occurred.

He urged that pupil distortion be addressed adequately when these rare cases develop.

“Don’t wait for atrophy to develop,” he underscored.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.